Brain Disorders
Topics
- Acquired Cognitive Impairment
- Alzheimer's Disease
- Traumatic Brain Injury (TBI)
- Amyotrophic Lateral Sclerosis (ALS)
- Dementia
- Fetal Alcohol Spectrum Disorders (FASD)
- Transmissible Spongiform Encephalopathy (TSE)
- Frontotemporal Dementia (FTD)
- Multiple Sclerosis
- Anorexia
- Lewy Body Dementia
- Vascular Contributions to Cognitive Impairment & Dementia (VCID)
- Anxiety Disorders
- Aphasia
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Autism
- Batten Disease
- Bipolar Disorder
- Brain Cancer
- Cerebral Palsy
- Cerebrovascular Health
- Depression
- Down Syndrome
- Eating Disorders
- Epilepsy
- Fragile X
- Huntington's Disease
- Hydrocephalus
- Intellectual & Development Disabilities (IDD)
- Migraines
- Parkinson's Disease
- Post-Traumatic Stress Disorder (PTSD)
- Rett Syndrome
- Schizophrenia
- Stroke
- Tourette Syndrome
- Tuberous Sclerosis
NIA-Funded Alzheimer's Disease Research Centers
NIA-designated Alzheimer’s Disease Research Centers (ADRCs) serve as a national resource for research on the nature of Alzheimer’s disease (AD) and AD-related dementias (ADRD) and the development of more effective approaches to prevention, diagnosis, care, and therapy. They create shared resources that support dementia-relevant research.
Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions Frequently Asked Questions (FAQs)
- Overview
- Request for Applications (RFA)
- Technical Assistance (TA) Webinar
- NIH RFA Contacts
- FAQs (Includes new FAQs as of 8/08/24)
Overview
NIH created the Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions Program in response to the Children’s Health Act of 2000.
CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect
Overview
NIH has funded research on the prevalence, causes, course, and immediate and long-term consequences of physical, sexual, and emotional child abuse and neglect—now called child maltreatment—for the past few decades. Results of these efforts indicate that child and adolescent victims of abuse are likely to have a legacy of physical and mental problems well into adulthood.
Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions
In June 2024, NIH published RFA-HD-25-002 : Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional).
Please note: In July 2024, NIH issued NOT-HD-24-026 : Notice to Extend the Application Receipt Date for RFA-HD-25-002, which extends the Request for Applications (RFA) deadline to August 20, 2024.
Collaborative Programs of Excellence in Autism (CPEAs)/Studies to Advance Autism Research & Treatment (STAART) Centers (For Historical Purposes Only)
These projects were superseded by the Autism Centers of Excellence Program and are no longer active. Information on these projects is not being updated and is intended for historical purposes only.
Neurocognitive Aging Section
Peter Rapp , Ph.D., Chief
Magnetic Resonance Imaging and Spectroscopy Section
Richard Spencer , Ph.D., M.D., Chief
Genome Instability and Chromatin Remodeling Section
Weidong Wang , PhD, Chief
Brain Aging and Behavior Section
The overall goal of the Brain Aging and Behavior Section (BABS) is to improve cognitive outcomes with aging.
Neuromuscular Diseases Research Section
Bryan J. Traynor , M.D., Ph.D., Chief
The Neuromuscular Diseases Research Section investigates the causes and biology of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Our focus is on turning discoveries into better diagnosis and faster development of treatments. We combine large-scale human genetics with detailed molecular profiling to understand disease processes, improve patient grouping, and create biomarkers and outcome tools for clinical trials.